MHRA Response to contaminated paediatric medicines
On the 7th of October The Medicines and Healthcare products Regulatory Agency (MHRA) released a response to contaminated paediatric medicines identified by the WHO region of Africa.
Hottest Summer on record – Key Transport Learnings
The Hottest summer on record occurred this year with temperatures soaring to 40oC in July 2022. As a medicinal product wholesaler what key learnings with regards to your transport have you taken away?
Pulling your hair out over advertising your medicine?
A healthcare company has been investigated over advertising an over-the-counter hair regrowth medicine which provides a money-back guarantee.
New gene-editing regulation bill in Parliament discussion
A bill is currently being reviewed in the House of Commons regarding gene-editing of plants and animals and products produced from genetically modified organisms (GMOs).
PSNC to expand pharmacy technician role
The Pharmaceutical Services Negotiating Committee (PSNC) are currently in the negotiating the expanding of the role of the pharmacy technician to provide more key services within a pharmacy.
Are you a Registered Pharmacist?
Are you a Registered Pharmacist? Have you carried out your Revalidation?
Superintendent Pharmacist training and support
Superintendent Pharmacist training and support – Many pharmacists don’t feel confident or have a full understanding of the role and responsibilities of a superintendent pharmacists.
Does the GPhC have enough power to regulate online pharmacy and large corporates?
Executives at the Professional Standards Authority (PSA) have recognised and suggested that the GPhC would need more regulatory powers to manage online pharmacies and larger corporate pharmacy companies.
Large Pharmacy Multiples Reducing Hours
Morrisons is the latest supermarket to announce cut down of hours in its stores which operate pharmacies. This announcement has come in order to give the staff a better work life balance and look after their wellbeing, Morrison’s claims.
Early Access to Medicines Scheme (EAMS): Sickle Cell Disease
The Early Access to Medicines Scheme (EAMS) launched in 2014 and allows patients with unmet clinical needs to gain early access to unlicensed medicines and medicines to be used outside of their licence.